Bandhan Healthcare Fund
Bandhan Mutual Fund · FM: Viraj Kulkarni, Brijesh Shah, Ritika Behera, Gaurav Satra · INF194KB1KF5 · Direct
NAV ₹11.50 AUM ₹319 Cr as of 22 Sep 2026
Portfolio as of Jul 2026 · Last Update: 16-Aug-2026 05:03 PM IST
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | -0.6% | +1.5% | +7.8% | +23.8% | — | — | — | 222/234 | 1.31% |
Equity allocation
96.48%
Non-equity allocation (combined)
3.52%
All Equity Holdings (34) as of Jul 2026
| # | Company | Value (₹ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 34.8 | 10.91% | — |
| 2 | Apollo Hospitals Enterprise Limited | 26.9 | 8.41% | — |
| 3 | Cipla Limited | 22.1 | 6.92% | — |
| 4 | Torrent Pharmaceuticals Limited | 14.4 | 4.50% | — |
| 5 | Divi's Laboratories Limited | 12.9 | 4.04% | — |
| 6 | Aurobindo Pharma Limited | 12.6 | 3.96% | — |
| 7 | Global Health Limited | 11.5 | 3.61% | — |
| 8 | Dr. Reddy's Laboratories Limited | 11.5 | 3.59% | — |
| 9 | Glenmark Pharmaceuticals Limited | 11.2 | 3.50% | — |
| 10 | Dr. Lal Path Labs Limited | 11.1 | 3.46% | — |
| 11 | Max Healthcare Institute Limited | 11.0 | 3.44% | — |
| 12 | Ajanta Pharma Limited | 9.4 | 2.93% | — |
| 13 | Zydus Lifesciences Limited | 8.9 | 2.80% | — |
| 14 | GlaxoSmithKline Pharmaceuticals Limited | 8.0 | 2.49% | — |
| 15 | Shilpa Medicare Limited | 8.0 | 2.49% | — |
| 16 | Rainbow Childrens Medicare Limited | 7.6 | 2.39% | — |
| 17 | Abbott India Limited | 7.0 | 2.18% | — |
| 18 | Healthcare Global Enterprises Limited | 6.7 | 2.10% | — |
| 19 | Pfizer Limited | 6.3 | 1.96% | — |
| 20 | Syngene International Limited | 6.2 | 1.93% | — |
| 21 | Eris Lifesciences Limited | 6.1 | 1.92% | — |
| 22 | IPCA Laboratories Limited | 6.1 | 1.92% | — |
| 23 | Lupin Limited | 5.4 | 1.70% | — |
| 24 | Orchid Pharma Limited | 5.4 | 1.70% | — |
| 25 | Narayana Hrudayalaya Limited | 5.1 | 1.59% | — |
| 26 | Novartis India Limited | 4.9 | 1.54% | — |
| 27 | Sanofi India Limited | 4.6 | 1.45% | — |
| 28 | Thyrocare Technologies Limited | 4.6 | 1.45% | — |
| 29 | Sai Life Sciences Limited | 4.0 | 1.24% | — |
| 30 | Alivus Life Sciences Limited | 3.7 | 1.17% | — |
| 31 | Medi Assist Healthcare Services Limited | 3.2 | 1.01% | — |
| 32 | Sai Parenterals Limited | 3.1 | 0.97% | — |
| 33 | Viyash Scientific Limited | 2.5 | 0.77% | — |
| 34 | Concord Biotech Limited | 1.4 | 0.44% | — |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.